Actinium Pharmaceuticals reported $-5.13M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Actinium Pharmaceuticals USD -5.13M 1.75M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Pfizer USD 3.33B 290M Sep/2025